Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RAPT | Exit | RAPT Therapeutics Inc | $0 | – | -145,401 | -100.0% | -9.14% | – |
NRIX | Exit | Nurix Therapeutics Inc | $0 | – | -327,123 | -100.0% | -11.14% | – |
RVMD | Exit | Revolution Medicines Inc | $0 | – | -685,011 | -100.0% | -35.31% | – |
NGM | Exit | NGM Biopharmaceuticals Inc | $0 | – | -1,298,908 | -100.0% | -44.41% | – |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NGM Biopharmaceuticals Inc | 8 | Q3 2022 | 45.2% |
Revolution Medicines Inc | 8 | Q3 2022 | 38.8% |
Nurix Therapeutics Inc | 8 | Q3 2022 | 24.9% |
RAPT Therapeutics Inc | 8 | Q3 2022 | 9.7% |
Constellation Pharmaceuticals Inc. | 3 | Q2 2021 | 43.1% |
View Ponoi II Management, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
4 | 2024-04-08 |
4 | 2023-11-17 |
4 | 2023-02-01 |
4 | 2023-01-25 |
4 | 2023-01-23 |
4 | 2023-01-17 |
4 | 2023-01-12 |
4 | 2022-12-14 |
4 | 2022-11-23 |
13F-HR | 2022-11-14 |
View Ponoi II Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.